FindTrial
Sign In

Bacterial contamination of cell salvaged blood before and after bile duct anastomosis during liver transplantation

Bacterial contamination of cell salvaged blood before and after bile duct anastomosis during liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002947
Enrollment
17
Registered
2018-06-22
Start date
2018-06-11
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients who scheduled for liver transplantation to treat end-stage liver disease (eg, liver cancer, liver cirrhosis, liver failure, hepatitis, etc.)

Exclusion criteria

Exclusion criteria: child who is under 30 kg or less in the pediatric population In cases which cell saver were not applied during surgery

Design outcomes

Primary

MeasureTime frame
Blood collected by cell saver before and / after the anastomosis procedure is collected to evaluate the changes in the degree of bacterial contamination within the blood.—

Secondary

MeasureTime frame
After the biliary anastomosis, the blood collected from the autologous blood transfusion apparatus and the difference in blood bacterial contamination after the leukocyte removal filter was applied are evaluated—

Countries

Korea, Republic of

Contacts

Public ContactDoyeon Kim

Samsung Medical Center

kimdoyeon31@gmail.com+82-2-3410-0369

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026